Fatty Liver Unknown Status Phase 3 Trials for Pioglitazone (DB01132)

Also known as: Liver fatty / Infiltration fatty liver / Fatty liver metamorphosis / Liver fatty metamorphosis / Metamorphosis fatty liver / Liver fatty degeneration / Degeneration fatty liver / Liver fatty infiltration / Fatty liver infiltration / Steatosis of liver (disorder) / Liver fatty change / Steatosis hepatic / Hepatic steatosis / Steatohepatitis (disorder) / Steatohepatitis

IndicationStatusPhase
DBCOND0028942 (Fatty Liver)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02265276
A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr DiseaseTreatment